| Ytd | 69.06% | |
| 1y | 127.44% |
| Open | 20.46 | Prev Close | 20.45 | Low | 19.55 | High | 20.73 | Mkt Cap | 324.16M |
| Vol | 32.93K | Avg Vol | 338.87K | EPS | -17.37 | P/E | N/A | Forward P/E | -0.63 |
| Beta | 1.55 | Short Ratio | 2.47 | Inst. Own | 77.14% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-15 | 50-d Avg | 25.55 | 200-d Avg | 21.96 | 1yr Est | 11.50 |
Sutro Biopharma (NASDAQ: STRO - Get Free Report) and Cardio Diagnostics (NASDAQ: CDIO - Get Free Rep
Citizens analyst Reni J. Benjamin maintains Sutro Biopharma (NASDAQ:STRO) with a Market Outperfor
Wedbush analyst David Nierengarten reiterates Sutro Biopharma (NASDAQ:STRO) with a Outperform and
Sutro Biopharma stock falls after its STRO-004 Phase 1 update, with DLTs reported at the highest dos
Gainers BioVie (NASDAQ:BIVI) shares increased by 39.4% to $1.77 during Wednesday's regular sess
Dow Jones up 0.1%, NASDAQ up 0.47%, S&P 500 up 0.24%. Tech stocks up 1.1%, communication service
Sutro Biopharma (NASDAQ:STRO) reported quarterly losses of $(2.33) per share which missed the analys
Truist Securities analyst Supawat Thongthip assumes Sutro Biopharma (NASDAQ:STRO) with a Buy rati
Barclays analyst Lukas Shumway initiates coverage on Sutro Biopharma (NASDAQ:STRO) with a Overwei
U.S. stock futures lower with Nasdaq down 200 points. XP Inc (XP) falls after reporting lower-than-e
Agilysys Inc (AGYS) shares rose in pre-market trading after reporting better-than-expected financial
Leerink Partners maintains Sutro Biopharma (NASDAQ:STRO) with a Outperform and raises the price ta
Wedbush analyst David Nierengarten upgrades Sutro Biopharma (NASDAQ:STRO) from Neutral to Outperf
Dow Jones falls 400 points, while Gemini Space Station Inc (NASDAQ: GEMI) sees 25.7% jump after stro
Analysts change outlook on top Wall Street names. Piper Sandler cuts target for Figma to $30, Roth C
HC Wainwright & Co. analyst Andres Y. Maldonado maintains Sutro Biopharma (NASDAQ:STRO) with
Sutro Biopharma (NASDAQ:STRO) reported quarterly losses of $(2.94) per share which beat the analyst
Top analysts change outlook on top names, including upgrades, downgrades, and initiations. Check out
Mizuho analyst Salim Syed initiates coverage on Sutro Biopharma (NASDAQ:STRO) with a Outperform r
Citizens analyst Reni J. Benjamin maintains Sutro Biopharma (NASDAQ:STRO) with a Market Outperfor
STRO-004 demonstrates robust and consistent antitumor activity across multiple TF-expressing solid t
Citizens analyst Reni J. Benjamin maintains Sutro Biopharma (NASDAQ:STRO) with a Market Outperfor
Deutsche Bank analyst James Shin maintains Sutro Biopharma (NASDAQ:STRO) with a Buy and raises th
Analysts change ratings & price targets for HSCS, ONDS, STRO, PFE, HST, CABA, INSM, PVH. See ful
Top Wall Street analysts upgraded STRO, JKS, AJG, ECL, RL stocks. See analysts' ratings and pric
Wells Fargo analyst Eva Fortea Verdejo upgrades Sutro Biopharma (NASDAQ:STRO) from Equal-Weight t
HC Wainwright & Co. analyst Andres Y. Maldonado upgrades Sutro Biopharma (NASDAQ:STRO) from N
Sutro Biopharma (NASDAQ:STRO) reported quarterly losses of $(5.29) per share which missed the analys
Shares of Kodiak Sciences Inc. (NASDAQ: KOD) fell sharply during Thursday’s session after the comp
During the session on Thursday, 461 stocks hit new 52-week lows.
During Tuesday's session, 275 companies made new 52-week lows.
During the Friday's sesion, 157 stocks hit new 52-week lows.
On Wednesday, 155 companies set new 52-week lows.
Gainers CaliberCos Inc. (NASDAQ: CWD) shares jumped 65.6% to $9.94 amid post-IPO volatility.
Gainers Applied Genetic Technologies Corporation (NASDAQ: AGTC) climbed 62.4% to close at $0.39.
On Tuesday, 951 companies hit new 52-week lows.
During Monday's trading, 1214 companies set new 52-week lows.